News from the healthcare data industry
October 06, 2022 10:30 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration to develop a companion diagnostic (CDx) test...
Oct 5, 2022 For patients with mCSPC, the current standard of treatment is to intensify androgen deprivation therapy (ADT) with docetaxel or androgen receptor axis-targeted therapy (ARAT: abiraterone, apalutamide, enzalutamide)....
LexisNexis Gravitas Network leverages patient-centric, referential tokenization to accelerate clinical research and precision medicine ATLANTA, Oct. 5, 2022 /PRNewswire/ — LexisNexis Risk Solutions, the leading provider of healthcare data analytics and technology, today...
Conduct disease-specific and disease-agnostic analyses Our disease-agnostic datasets combine 20 disease-specific data models with a lighter-weight data model for all other histologies to enable robust pan-tumor analyses. Patient data across...
New clinical workflow software aims to solve timing challenges in neurovascular emergencies for the entire care team CAMBRIDGE, Mass., Oct. 5, 2022 /PRNewswire/ — ConcertAI’s TeraRecon, the leading AI and advanced visualization platform...
BOWIE, Md., Oct. 04, 2022 (GLOBE NEWSWIRE) — Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced the launch of RCM Intelligence. Powered by integrated analytics and...
Background – Colorectal liver oligometastases (CLO) represents a subset of metastatic colorectal cancer (mCRC) patients who may be eligible to undergo curative intent resection which can improve survival. However, given the...
In September, leaders from across healthcare gathered in Washington, D.C. to discuss emerging opportunities and challenges around the use of health data to improve patient outcomes. Source: https://datavant.com/summit-2022/
Not all chronic diseases receive equal attention. Funding, visibility, and treatment are influenced by factors ranging from pop culture and publicity to taboo and stigma. Sickle cell disease (SCD) and...
This webinar is on-demand and can be viewed at your convenience. Real-world evidence has advanced health research over the past two to three decades. But the challenges of procuring sufficient,...